TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
DNTH

Dianthus Therapeutics Inc.

Healthcare · Biotechnology · —

90.70$ -2.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement DNTH
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – 0.43 1.71 0.55 0.19 0.05
0.00 0.17 0.42 0.80 0.72 0.59 0.04 0.07 0.01 –
0.00 -0.17 -0.42 -0.80 -0.72 0.43 1.71 0.55 0.19 0.05
2.62 12.62 19.85 24.80 17.72 3.67 7.84 6.37 2.49 3.85
1.58 3.54 8.94 10.27 10.23 0.57 1.80 3.52 0.75 0.91
4.19 15.99 28.38 35.07 27.95 4.24 9.64 9.90 3.24 4.76
-4.19 -16.16 -28.80 -35.86 -28.67 -3.81 -7.93 -9.35 -3.06 -4.71
0.07 – – – 1.37 1.04 – – – –
-4.27 -16.05 -27.62 -33.18 -27.30 -3.82 -7.60 -8.45 -2.55 -4.30
– 0.11 1.18 2.68 2.74 -0.58 -0.34 0.04 – –
-4.27 -16.05 -27.62 -33.18 -27.30 -3.82 -7.60 -8.45 -2.55 -4.30
-4.19 -15.88 -27.20 -32.39 -26.58 -3.23 -7.56 -8.38 -2.54 -4.28

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?